These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
605 related items for PubMed ID: 19800456
1. American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis--4-year data in 194 treated lesions. Keisch M, Vicini F, Beitsch P, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Zannis V, Kuerer H. Am J Surg; 2009 Oct; 198(4):505-7. PubMed ID: 19800456 [Abstract] [Full Text] [Related]
2. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Vicini F, Beitsch PD, Quiet CA, Keleher AJ, Garcia D, Snider HC, Gittleman MA, Zannis VJ, Kuerer HM, Lyden M. Cancer; 2008 Feb 15; 112(4):758-66. PubMed ID: 18181095 [Abstract] [Full Text] [Related]
3. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R. Am J Surg; 2006 Oct 15; 192(4):427-33. PubMed ID: 16978943 [Abstract] [Full Text] [Related]
4. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Benitez PR, Keisch ME, Vicini F, Stolier A, Scroggins T, Walker A, White J, Hedberg P, Hebert M, Arthur D, Zannis V, Quiet C, Streeter O, Silverstein M. Am J Surg; 2007 Oct 15; 194(4):456-62. PubMed ID: 17826055 [Abstract] [Full Text] [Related]
5. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast. Jeruss JS, Vicini FA, Beitsch PD, Haffty BG, Quiet CA, Zannis VJ, Keleher AJ, Garcia DM, Snider HC, Gittleman MA, Whitacre E, Whitworth PW, Fine RE, Arrambide S, Kuerer HM. Ann Surg Oncol; 2006 Jul 15; 13(7):967-76. PubMed ID: 16788759 [Abstract] [Full Text] [Related]
6. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience. Sahoo S, Recant WM, Jaskowiak N, Tong L, Heimann R. Breast J; 2005 Jul 15; 11(4):242-7. PubMed ID: 15982389 [Abstract] [Full Text] [Related]
7. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial. Shah C, Badiyan S, Ben Wilkinson J, Vicini F, Beitsch P, Keisch M, Arthur D, Lyden M. Ann Surg Oncol; 2013 Oct 15; 20(10):3279-85. PubMed ID: 23975302 [Abstract] [Full Text] [Related]
8. Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial. Goyal S, Khan AJ, Vicini F, Beitsch PD, Lyden M, Keisch M, Haffty BG. Ann Surg Oncol; 2009 Sep 15; 16(9):2450-8. PubMed ID: 19517191 [Abstract] [Full Text] [Related]
9. Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System registry trial. Khan AJ, Vicini F, Beitsch P, Haffty B, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Zannis V, Kuerer H, Whitacre E, Whitworth P, Fine R. Ann Surg Oncol; 2009 Jun 15; 16(6):1612-8. PubMed ID: 19319606 [Abstract] [Full Text] [Related]
10. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Vicini FA, Beitsch PD, Quiet CA, Keleher A, Garcia D, Snider HC, Gittleman MA, Zannis VJ, Kuerer H, Whitacre EB, Whitworth PW, Fine RE, Haffty BG, Arrambide LS. Cancer; 2005 Sep 15; 104(6):1138-48. PubMed ID: 16088962 [Abstract] [Full Text] [Related]
11. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA. Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1514-21. PubMed ID: 16005576 [Abstract] [Full Text] [Related]
12. Axillary failure in patients treated with MammoSite accelerated partial breast irradiation. Aburabia M, Roses RE, Kuerer HM, Fine R, Beitsch PD, Goyal S, Haffty B, Lyden M, Vicini FA. Ann Surg Oncol; 2011 Nov 01; 18(12):3415-21. PubMed ID: 21537870 [Abstract] [Full Text] [Related]
13. Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy. Benitez PR, Chen PY, Vicini FA, Wallace M, Kestin L, Edmundson G, Gustafson G, Martinez A. Am J Surg; 2004 Oct 01; 188(4):355-64. PubMed ID: 15474426 [Abstract] [Full Text] [Related]
14. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Polgár C, Major T, Fodor J, Németh G, Orosz Z, Sulyok Z, Udvarhelyi N, Somogyi A, Takácsi-Nagy Z, Lövey K, Agoston P, Kásler M. Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1173-81. PubMed ID: 15519789 [Abstract] [Full Text] [Related]
15. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. Solin LJ, McCormick B, Recht A, Haffty BG, Taylor ME, Kuske RR, Bornstein BA, McNeese M, Schultz DJ, Fowble BL, Barrett W, Yeh IT, Kurtz JM, Amalric R, Fourquet A. Cancer J Sci Am; 1996 Nov 15; 2(3):158-65. PubMed ID: 9166516 [Abstract] [Full Text] [Related]
16. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history. Hiramatsu H, Bornstein BA, Recht A, Schnitt SJ, Baum JK, Connolly JL, Duda RB, Guidi AJ, Kaelin CM, Silver EB, Harris JR. Cancer J Sci Am; 1995 Nov 15; 1(1):55-61. PubMed ID: 9166455 [Abstract] [Full Text] [Related]
17. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience. Chao KK, Vicini FA, Wallace M, Mitchell C, Chen P, Ghilezan M, Gilbert S, Kunzman J, Benitez P, Martinez A. Int J Radiat Oncol Biol Phys; 2007 Sep 01; 69(1):32-40. PubMed ID: 17467920 [Abstract] [Full Text] [Related]
18. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Pawlik TM, Perry A, Strom EA, Babiera GV, Buchholz TA, Singletary E, Perkins GH, Ross MI, Schecter NR, Meric-Bernstam F, Ames FC, Hunt KK, Kuerer HM. Cancer; 2004 Feb 01; 100(3):490-8. PubMed ID: 14745864 [Abstract] [Full Text] [Related]
19. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy. Ciervide R, Dhage S, Guth A, Shapiro RL, Axelrod DM, Roses DF, Formenti SC. Int J Radiat Oncol Biol Phys; 2012 Jun 01; 83(2):e159-64. PubMed ID: 22579378 [Abstract] [Full Text] [Related]
20. Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI. Vicini F, Shah C, Ben Wilkinson J, Keisch M, Beitsch P, Lyden M. Ann Surg Oncol; 2013 Apr 01; 20(4):1275-81. PubMed ID: 23054123 [Abstract] [Full Text] [Related] Page: [Next] [New Search]